Article Versions Notes

Salehi F, Zarifi S, Bayat S, Habibpour M, Asemanrafat A, Kleyer A, Schett G, Fritsch-Stork R, Eskofier BM. Predicting Disease Activity Score in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs Using Machine Learning Models. Technologies. 2025; 13(8):350. https://doi.org/10.3390/technologies13080350

Salehi, Fatemeh, Sara Zarifi, Sara Bayat, Mahdis Habibpour, Amirreza Asemanrafat, Arnd Kleyer, Georg Schett, Ruth Fritsch-Stork, and Bjoern M. Eskofier. 2025. "Predicting Disease Activity Score in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs Using Machine Learning Models" Technologies 13, no. 8: 350. https://doi.org/10.3390/technologies13080350

Salehi, F., Zarifi, S., Bayat, S., Habibpour, M., Asemanrafat, A., Kleyer, A., Schett, G., Fritsch-Stork, R., & Eskofier, B. M. (2025). Predicting Disease Activity Score in Rheumatoid Arthritis Patients Treated with Biologic Disease-Modifying Antirheumatic Drugs Using Machine Learning Models. Technologies, 13(8), 350. https://doi.org/10.3390/technologies13080350